Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer

BACKGROUND: Advanced, unresectable pancreatic cancer is an extremely aggressive disease. The 5-year survival rate for pancreatic cancer is only less than 5%. Current therapeutic options for patients with locally advanced or metastatic disease are limited. This analysis is a retrospective evaluation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Korean J Intern Med
Autores principales: Min, Young Joo, Joo, Kwang Ro, Park, Neung Hwa, Yun, Tae Kwon, Nah, Yang Won, Nam, Chang Woo, Park, Jae Hoo
Formato: Artigo
Lenguaje:Inglês
Publicado: Korean Association of Internal Medicine 2002
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531686/
https://ncbi.nlm.nih.gov/pubmed/12647642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2002.17.4.259
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares